KFKehinde Oluwafemi Fabiyi

Kehinde Oluwafemi Fabiyi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kehinde Oluwafemi Fabiyi has a total of 11 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Pandemic Preparedness, Resilience, and Recovery in Health Systems

    by Kehinde Oluwafemi Fabiyi, Jennifer Tettey, Peter Aduvie Josiah, Akamien Joanna, Olawale Adetunji Adediran, Oluwatomilayo Oluwayinka Fasesin, Leo Tata

    Pandemics and public health emergencies expose vulnerabilities in healthcare systems, disrupt other sectors that provide essential services, and exacerbate socioeconomic inequalities among populations. This narrative review assesses components of pandemic preparedness, health system resilience, and strategies of recovery from a global health crisis. Lessons from COVID-19 and other previous pandemics—such as the importance of early warning systems, robust surveillance, adaptive workforce deployment, sustainable supply chains, and strong governance are considered. In addition to preparation for and management of a pandemic, a health system must not only absorb shock to be considered resilient, but also adapt and transform to deal with a crisis. This healthcare transformation can be achieved through adopting digital health information systems, new methods of healthcare financing, and active involvement of local communities. The importance of protecting essential health services, such as immunization, maternal healthcare, and management of patients with chronic diseases, is highlighted. The review also addresses the disproportionate impact of these health crises on vulnerable populations such as people of low socioeconomic status, the elderly, and displaced people. Finally, recommendations are provided on how to strengthen global health security by strengthening primary health care, ensuring equitable distribution of resources, and investing in local manufacturing of health products and in digital health information systems. Building back better in the aftermath of a pandemic will require sustained political will and, most importantly, international solidarity and a fundamental shift from a health crisis reaction model to a model of equity-centered preparedness and proactiveness. Investment in primary health care, digital health technologies, local manufacturing of health products and emergency preparedness are key to future health security. Strong pandemic preparedness and resilience require sustained political commitment, global solidarity and an equity-oriented proactive approach to protect the world’s population in the face of a health crisis.

  • Open Access

    Mapping and characterizing persistent HIV reservoirs in early-treated individuals: Implications for cure-focused interventions

    by Kehinde Oluwafemi Fabiyi, Fortune Itoje Ebiala, Vivian Ifeyinwa Eze, Victor Olawale Bejide, Blessing Ometere Ayeni, Maryam Olayemi Bakare

    Despite the transformative impact of antiretroviral therapy (ART), HIV persists in long-lived cellular and anatomical reservoirs that reignite viral replication when treatment is interrupted. Eliminating or durably suppressing these reservoirs remains the central challenge to achieving a cure. Individuals who initiate ART during acute or early infection provide a particularly informative model, as early intervention is generally associated with reduced reservoir size, limited viral diversification, preservation of immune function, and lower levels of inflammation. These features create a valuable biological window for interrogating the earliest events of reservoir seeding and persistence. Recent advances in reservoir mapping including high-sensitivity molecular assays, full-length proviral sequencing, single-cell multi-omics, and spatial imaging have enabled increasingly refined characterization of reservoir composition, cellular identity, clonal dynamics, and tissue distribution. Studies in early-treated cohorts have identified features such as simplified clonal architecture, higher relative inducibility of intact proviruses, and, in some individuals, an increased likelihood of post-treatment control. These insights are informing the development of cure-focused interventions ranging from latency reversal and immune-based strategies to gene-editing approaches and targeted drug delivery. Nonetheless, important challenges remain, including incomplete tissue sampling, assay sensitivity limitations, and uncertainty regarding which cellular and anatomical reservoirs most critically drive viral rebound. Integrative approaches combining multi-omics profiling, predictive biomarkers, and personalized therapeutic strategies will be essential for advancing toward durable ART-free remission.